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IL-22 is an IL-10 family cytokine that initiates innate
immune responses against bacterial pathogens and
contributes to immune disease. IL-22 biological ac-
tivity is initiated by binding to a cell-surface complex
composed of IL-22R1 and IL-10R2 receptor chains
and further regulated by interactions with a soluble
binding protein, IL-22BP, which shares sequence
similarity with an extracellular region of IL-22R1
(sIL-22R1). IL-22R1 also pairs with the IL-20R2 chain
to induce IL-20 and IL-24 signaling. To define the
molecular basis of these diverse interactions, we
have determined the structure of the IL-22/sIL-22R1
complex. The structure, combined with homology
modeling and surface plasmon resonance studies,
defines the molecular basis for the distinct affinities
and specificities of IL-22 and IL-10 receptor chains
that regulate cellular targeting and signal transduc-
tion to elicit effective immune responses.
INTRODUCTION
Interleukin-22 (IL-22) is an a-helical cytokine produced by acti-
vated DC and T cells, including the recently identified Th17 line-
age (Dumoutier et al., 2000a; Liang et al., 2006). Despite its pro-
duction by immune cells, IL-22 biological activity is specifically
targeted to cells of epithelial origins, where it induces pro-inflam-
matory activities that include the production of early systemically
circulated defense proteins (acute phase proteins) (Dumoutier
et al., 2000b). More recently, IL-22 has been shown to induce
antimicrobial proteins, including S100s and defensins, in colonic
and lung epithelial cells, which are critical for host defense
against enteric and pulmonary bacterial pathogens (Aujla et al.,
2008; Liang et al., 2006; Wolk et al., 2004; Zheng et al., 2008).
This suggests that IL-22 allows coordination between the adap-
tive and innate immune systems to fight invading pathogens.
In addition to its pro-inflammatory activities, IL-22 confers
a protective effect on the liver by promoting hepatocyte survival
(Radaeva et al., 2004; Zenewicz et al., 2007). IL-22 also en-
hances lung epithelial cell proliferation and the maintenance of
trans-epithelial resistance to injury (Aujla et al., 2008). IL-22-me-
diated protective effects have also been observed in the gut,
where IL-22 knockout mice, subjected to Citrobacter rodentiumStructure 16, 1333–134infection, exhibit increased epithelial cell damage and increased
mortality (Zheng et al., 2008). Thus, IL-22 exhibits paradoxical
pro- and anti-inflammatory properties on epithelial cells, which
are strikingly similar to the activity profile of IL-10 on immune
cells (Moore et al., 2001).
IL-22 and IL-10 induce cellular responses by engaging heter-
odimeric cell-surface receptor complexes that contain IL-22R1
and IL-10R1 chains, respectively, and the shared signal trans-
ducing receptor, IL-10R2 (Figure 1; Kotenko et al., 2001a; Xie
et al., 2000). Formation of the IL-22/IL-22R1/IL-10R2 complex
activates intracellular kinases (JAK1, Tyk2, and MAP) and tran-
scription factors, especially STAT3, leading to IL-22 cellular re-
sponses (Lejeune et al., 2002). IL-10/IL-10R1/IL-10R2 assembly
induces overlapping kinases and also predominantly activates
STAT3 (Moore et al., 2001).
IL-22R1 is selectively expressed on skin and epithelial cells,
whereas IL-10R1 is predominantly expressed onDCcells,mono-
cytes, and macrophages (Nagalakshmi et al., 2004). In contrast,
IL-10R2 is expressed on all cell types, which reflects its role as
a shared receptor in IL-22, IL-10, IL-26, IL-28, and IL-29 receptor
complexes. Surface plasmon resonance (SPR) studies are
consistent with the targeting function of IL-22R1 and IL-10R1
(Logsdon et al., 2002, 2004; Yoon et al., 2005, 2006). sIL-22R1
and sIL-10R1 both exhibit high affinity (nM) for their respective
ligands. In contrast, IL-10R2 interactions are very weak (mM–
mM), which may facilitate promiscuous, but essential, interac-
tions inmultiple cytokine complexes resulting in cellular signaling
responses.
IL-22 and IL-10 are structurally similar to each other and to the
rest of the IL-10 cytokine family, which includes IL-19, IL-20,
IL-24, and IL-26 (Pestka et al., 2004). In addition to specific
high-affinity interactions with IL-22, IL-22R1 also pairs with
IL-20R2 to induce IL-20 and IL-24 signaling (Dumoutier et al.,
2001a; Figure 1). Like IL-22, IL-20 and IL-24 havebeen implicated
in skin homeostasis and pathology (Blumberg et al., 2001; Kunz
et al., 2006; Sa et al., 2007). IL-20 induces keratinocyte prolifera-
tion, and overexpression in mice leads to a psoriasis-like pheno-
type (Blumberg et al., 2001). In contrast to IL-22, IL-20 and IL-24
are expressed predominantly by monocytes and keratinocytes.
Under Th1 conditions, IL-22R1 and IL-20R2 chains are also ex-
pressed on keratinocytes (Kunz et al., 2006). This suggests that
IL-20 and IL-24, via the IL-22R1/IL-20R2 complex, may provide
a communication link between monocytes and keratinocytes,
as well as a feedback loop on keratinocytes themselves.
The high level of IL-22 in human psoratic plaques and its
pathogenic role in a mouse model of psoriasis suggest that4, September 10, 2008 ª2008 Elsevier Ltd All rights reserved 1333
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Structure of IL-22/sIL-22R1 Complexantagonists that block the IL-22/sIL-22R1 interaction may have
therapeutic potential (Boniface et al., 2007; Ma et al., 2008;
Wolk et al., 2006). Furthermore, cells tightly regulate IL-22 activ-
ities by expressing an IL-22 binding protein (IL-22BP), which
shares 34% sequence identity with the extracellular region of
IL-22R1 (sIL-22R1) (Dumoutier et al., 2001b; Kotenko et al.,
2001b; Wei et al., 2003; Xu et al., 2001). Three splice forms of hu-
man IL-22BP have been identified in human cells (Kotenko et al.,
2001b). Mature IL-22BP isoform 2 (IL-22BPI2; SWISS-PROT ID
Q969J5-2) is 210 amino acids long and predicted to adopt
a structure similar to sIL-22R1, whereas isoform 3 (IL-22BPI3;
SWISS-PROT ID Q969J5-3) is 109 amino acids long and should
adopt a structure similar to the sIL-22R1 D1 domain (Figure 1).
The biochemical properties and functional roles of the IL-22BP
isoforms have not been elucidated.
The fidelity of intracellular signaling between innate and adap-
tive immune systems is critical to balance pathogen elimination
versus damage to host tissues. IL-22 and IL-22R1 play critical
roles in this process, not only by activation of the IL-22/
IL-22R1/IL-10R2 complex, but through additional diverse inter-
actions between IL-22 and IL-22BP and the participation of IL-
22R1 in IL-20/IL-22R1/IL-20R2 and IL-24/IL-22R1/IL-20R2 com-
plexes. To understand the molecular basis of these protein/
protein interactions, we have determined the structure of the
IL-22/sIL-22R1 complex. Comparison of IL-22/sIL-22R1 and
IL-10/sIL-10R1 structures, combined with homology modeling
and SPR analysis of IL-22/IL-22BP and IL-22/IL-22R1/IL-10R2
complexes, provides a molecular understanding of how these
molecules form specific and promiscuous complexes with affin-




The IL-22/sIL-22R1 structure was solved by single-wavelength
anomalous dispersion (SAD) phasing and refined at 2.5 A˚ resolu-
tion to Rcryst and Rfree values of 22.2% and 27.0%, respectively
(see Table S1 available online). IL-22 used for crystallization
(IL-22N-QQ) contained no N-linked glycosylation, and sIL-22R1
(sIL-22R1DDQ) contains carbohydrate at one of three sites, Asn-
172sIL-22R1 (Jones et al., 2008), which is observed in the structure
(Figure 2). AsparaginesAsn-68IL-22 andAsn-97IL-22weremutated
to glutamine to make IL-22N-QQ, whereas asparagines Asn-
80sIL-22R1 and Asn-87sIL-22R1 were replaced by aspartic acids
and Thr-89sIL-22R1 was replaced by glutamine to make sIL-
22R1DDQ. IL-22N-QQ and sIL-22R1DDQ exhibit essentially the
same affinity for one another as their glycosylated counterparts
(Table 1), suggesting the IL-22N-QQ/sIL-22R1DDQ crystal struc-
ture (IL-22/sIL-22R1 throughout the rest of text) accurately
reflects the cell-surface IL-22/IL-22R1 complex.
Overall Structure of IL-22/sIL-22R1
IL-22 and sIL-22R1 form a 1:1 complex in the crystal (Figure 2).
sIL-22R1 adopts an L-shaped structure orienting its two fibro-
nectin type III (FBNIII) domains (D1 and D2) at approximately
right angles to one another. The structure of sIL-22R1 is similar
to sIL-10R1 (Josephson et al., 2001), except the D2 domain of
sIL-22R1 is rotated by 20, relative to sIL-10R1, about an
axis parallel to the D2 b strands. Although considerable confor-
mational differences are observed among free IL-22 structures
(Nagem et al., 2002; Xu et al., 2005), sIL-22R1-bound IL-22 mol-
ecules are essentially identical (root-mean-square deviation
[rmsd] = 0.36 A˚). The IL-22/sIL-22R1 complex is most similar
to one half of the dimeric IL-10/sIL-10R1 complex (Josephson
et al., 2001). Upon superposition of IL-22 onto one subunit of
the IL-10 dimer (2.7 A˚ rmsd, 109 atoms), the C termini of sIL-
22R1 and sIL-10R1 chains, prior to their entry into the mem-
brane, are separated by12 A˚ (Figure 2C). Despite similar archi-
tectures, IL-22/sIL-22R1 does not form an IL-10-like dimeric
complex in the crystal lattice.
The IL-22/sIL-22R1 Interface
The IL-22/sIL-22R1 interface consists of five sIL-22R1 loops (L2–
L6) located at the interface of the D1 and D2 domains, which
Figure 1. Schematic Diagram of Protein Complexes Formed by IL-22
Receptors
Although not shown, IL-10R2 also forms IL-20R1/IL-10R2 and IL-28R1/IL-
10R2 cell-surface complexes that activate IL-26, IL-28, and IL-29 signaling.







IL-22/sIL-22R1a 1.4 3 105 2.9 3 103 4.0 20 nM
sIL-22R1DDQ
a 1.5 3 105 1.9 3 103 6.1 13 nM
sIL-22R1DDQ
b 1.3 3 106 1.6 3 103 7.4 1 nM
IL-22BPI2 1.3 3 106b 1.7 3 106a 6834 1 pMc
IL-22BPI3b 6.7 3 105 2.4 3 103 4.8 4 nM
sIL-10R2d - - - 120 mM
IL-22:sIL-22R1/sIL-10R2d - - - 12 mM
IL-10/sIL-10R1e 5.70 3 105 2.60 3 104 44 0.47 nM
sIL-10R2f - - - mM
IL-10:sIL-10R1/sIL-10R2g - - - 234 mM
Affinities in the table are between italicized and nonitalicized components.
a Experiments performed on amine-coupled surfaces.
b Experiments performed using Ab-captured sIL-22R1 or IL-22BP
isoform surfaces.
c Kd derived from kon and koff values (koff/kon) determined in different
experiments. Reported values in footnotes a–c are the average of two
experiments.
d From Logsdon et al. (2004).
e From Yoon et al. (2006).
f From Logsdon et al. (2002).
g From Yoon et al. (2005). T1/2 = 0.693/koff.
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Structure of IL-22/sIL-22R1 Complexengage IL-22 residues presented on helix A, the AB loop, and
helix F (Figures 2 and 3). The interface may be separated into
two major contact surfaces, site 1a and site 1b. L2–L4 loops
within the D1 domain form contacts in site 1a, while loops L5
and L6, from D2, contact site 1b.
Site 1a contributes 72% of the total buried surface area and
11 of 12 hydrogen bond/salt bridge interactions in the IL-22/
sIL-22R1 complex (Figures 3 and 4; Table 2). The predominant
feature of site 1a is the insertion of Tyr-60sIL-22R1 and Gly-
61sIL-22R1 into a small cavity on IL-22 created at the intersection
of helix F and the AB loop (Figure 2B). The base of the cavity is
formed by helix F residues Lys-162IL-22 and Glu-166IL-22, which
each form hydrogen bonds to the OH atom of Tyr-60sIL-22R1.
Gly-61sIL-22R1 also forms a hydrogen bond with the O atom of
Thr-72IL-22 located in the AB loop. The contacts formed by
Tyr-60sIL-22R1 and Gly-61sIL-22R1 are identical to those previously
described in the IL-10/sIL-10R1 complex for residues Tyr-
43sIL-10R1, Gly-44sIL-10R1, Asp-44IL-10, Lys-138IL-10, and Glu-
142IL-10. Thus, the major site 1a binding epitope is conserved
in IL-22/sIL-22R1 and IL-10/sIL-10R1 complexes (Figure 4).
In contrast to the extensive site 1a interface, IL-22/sIL-22R1
site 1b is very small and distinct from IL-10/sIL-10R1 (Figures 2
and 4). It is made up almost entirely of van derWaals interactions
between IL-22 helix F residues, Met-172IL-22 and Arg-175IL-22,
and sIL-22R1 L6 residues, Thr-207sIL-22R1 and Trp-208sIL-22R1
(Figures 2B and 4E). Site 1b contains one salt bridge between
Lys-44IL-22, located in the preA helix, and Asp-162sIL-22R1,
located on the L5 loop.
Mechanisms Regulating IL-22/sIL-22R1
and IL-10/sIL-10R1 Affinity
Using the structures of IL-22/sIL-22R1 and IL-10/sIL-10R1, we
sought to explain the distinct binding kinetics of the complexes
(Table 1). Our past SPR analysis of IL-22/sIL-22R1 interactions
used amine-coupled IL-22, which can prevent the accurate esti-
mation of on-rates (Logsdon et al., 2002, 2004). To test for this
possibility, we redesigned our SPR experiment by injecting
IL-22 over sIL-22R1-His6 captured on an anti-His6 antibody sur-
face. Using this experimental setup, an on-rate of 1.3 3 106
M1s1 was obtained for the IL-22/sIL-22R1 interaction, which
is an9-fold increase over previous amine-coupled experiments
and6-fold faster than observed for the IL-10/sIL-10R1 interac-
tion (Table 1). Interestingly, the overall affinity of each complex is
similar (1 nM versus 0.47 nM), but the occupancy time of the
ligand on the receptor, quantified by the complex half-life (T1/2),
is 7.4 min for IL-22/sIL-22R1 versus 44 min for IL-10/sIL-10R1.
The amounts of buried surface area and specific contacts in
the IL-22/IL-22R1 and IL-10/sIL-10R1 complexes are consistent
with the observed binding kinetics. The IL-22/sIL-22R1 interface
buries 1585 A˚2 of surface compared to 1893 A˚2 for IL-10/
sIL-10R1. In both complexes, site 1a forms the predominant
contact surface. In IL-22/sIL-22R1, it consists of 1141 A˚2 of bur-
ied surface area and 11 of 12 hydrogen bonds identified in the
complex (Table 2). Similarly, the IL-10/sIL-10R1 site 1a interface
consists of 1249 A˚2 (9% larger than IL-22/sIL-22R1) and forms 10
hydrogen bonds (Yoon et al., 2005).
Larger differences are observed in site 1b, which consists of
444 A˚2 in IL-22/sIL-22R1 compared to 664 A˚ in IL-10/sIL-10R1
(a 33% difference). In addition, IL-10/sIL-10R1 site 1b containsStructure 16, 1333–134six hydrogen bonds compared to only one in IL-22/sIL-22R1
(Figures 4E and 4F). As a result, the number of hydrogen bonds
per 100 A˚2 of surface area (HB/100 A˚) is1.7 throughout the en-
tire IL-10/sIL-10R1 site 1 interface. In contrast, IL-22/sIL-22R1
site 1a and 1b interfaces exhibit HB/100 A˚ values of 1.9 and
0.5, respectively. These comparisons suggest that the reduced
size (buried surface area and contacts) of IL-22/sIL-22R1 site
1b is mainly responsible for its faster off-rate compared to
IL-10/sIL-10R1.
IL-22/IL-22BP Interactions
To further evaluate the role of site 1a and 1b in IL-22 binding
affinity, we studied the binding kinetics of IL-22BP isoforms
IL-22BPI2 and IL-22BPI3 for IL-22 (Figure 5; Table 1). Homology
models of IL-22/IL-22BPI2 and IL-22/IL-22BPI3 reveal IL-22BPI2
forms site 1a and 1b contacts with IL-22, whereas IL-22BPI3 only
forms site 1a contacts. With one exception, the models suggest
that all site 1a IL-22/IL-22R1 contacts are conserved in IL-22/
IL-22BPI2 and IL-22/IL-22BPI3 complexes (Table 2). Thus, the
IL-22/IL-22BPI3 complex essentially mimics an IL-22/sIL-22R1
site 1a interface. Using SPR methods, IL-22/IL-22BPI3 exhibits
a dissociation constant (Kd) of 4 nM compared to 1 nM for
the IL-22/sIL-22R1 complex (Figure 5; Table 1). The off-rate of
the IL-22/IL-22BPI3 complex (2.4 3 103 M1s1) is only 1.5-
fold faster than observed for the IL-22/sIL-22R1 complex.
Thus, both the structure analysis (Figure 4E) and SPR data
suggest site 1b contributes very little to the overall stability of
the IL-22/sIL-22R1 complex.
In contrast to sIL-22R1 and IL-22BPI3, homology modeling of
the IL-22/IL-22BPI2 complex suggests that the D2 domain of IL-
22BPI2 forms extensive site 1b contacts with IL-22 (Figure 5D).
Key features of this interface are five new salt bridge/hydrogen
bonds (Table 2) and the formation of a hydrophobic cluster com-
posed of Trp-116IL-22BPI2 and Leu-208IL-22BPI2 and IL-22 resi-
dues Phe-57IL-22, Phe-171IL-22, and Met-172IL-22.
Consistent with the homology model, SPR analysis revealed
a Kd of1 pM, with a T1/2 of 4.7 days, for the IL-22/IL-22BPI2 in-
teraction (Table 1). The extremely slow off-rate of the IL-22/
IL-22BPI2 complex was determined by a 22 hr SPR experiment
thatmonitored the dissociation of IL-22BPI2 fromamine-coupled
IL-22 surfaces (Figure 5). Because Asn-54IL-22 makes a putative
hydrogen bond with Asp-209IL-22BPI2, we characterized the loss
of IL-22BPI2 from amine-coupled surfaces of glycosylated
IL-22 (IL-22NNN), as well as IL-22 mutants where N-linked carbo-
hydrate attachment residues Asn-54IL-22 (IL-22QNN) and Asn-
68IL-22 (IL-22NQN) were changed to glutamines. Consistent with
our model, a total of 8 response elements (RU) of IL-22BPI2
dissociated from amine-coupled IL-22NNN and IL-22NQN in the
22 hr period, whereas 28 RU of IL-22BPI2 dissociated from the
IL-22QNN surface, presumably by disrupting the Asn-54
IL-22/
Asp-209IL-22BPI2 interaction by the glutamine mutation. These
studies further infer a link between high-affinity binding of
IL-22/IL-22BPI2 and IL-10/sIL-10R1 with the size of site 1b.
Specificity of IL-22/sIL-22R1
and IL-10/IL-10R1 Complexes
IL-22 and IL-10 cellular responses require efficient targeting to
specific cells via their high-affinity chains IL-22R1 and IL-10R1.
Closer structural analysis revealed that the conserved site 1a4, September 10, 2008 ª2008 Elsevier Ltd All rights reserved 1335
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Structure of IL-22/sIL-22R1 ComplexFigure 2. Structure of the IL-22/IL-22R1 Complex
(A) Ribbon diagram of the IL-22/IL-22R1 complex. Helix A/AB loop and helix F that form the sIL-22R1 binding site are colored red and blue, respectively. Boxes
show the location of (B) and (E), respectively.
(B) IL-22/sIL-22R1 site 1 interface.
(C) Superposition of IL-22/sIL-22R1 and one half of the IL-10/sIL-10R1 dimer structure. IL-22 is colored red, sIL-22R1 is magenta, IL-10 is green, and sIL-10R1 is
cyan.
(D) Structural differences, including the role of carbohydrate, between sIL-22R1 and sIL-10R1 D2 domains.
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Structure of IL-22/sIL-22R1 ComplexFigure 3. IL-22 and IL-10 Exhibit Distinct Site 1 Structures and Binding Surfaces
(A) Superposition of IL-22 and IL-10 site 1 binding epitopes are colored as described in Figure 2C.
(B–D) Bar graph of IL-22 and IL-10 surface area buried in the site 1 interfaces of IL-22/sIL-22R1 and IL-10/sIL-10R1. Space-filling models are colored according to
the amount of surface area buried (red, greatest; dark blue, least) at each residue position in the IL-22 (C) and IL-10 (D) site 1 interfaces.L2/AB loop recognition motif, which consists of Tyr-60sIL-22R1
and Gly-61sIL-22R1, is a critical specificity determinant (Figure 4).
This is because the precise geometry of the hydrogen bonds
formed by these residues cannot be accurately reproduced in
noncognate complexes (e.g., IL-22/sIL-10R1 or IL-10/sIL-22R1)
without steric clashes between other regions of the molecules
(Figure 2C).
For example, superposition of IL-22 onto IL-10/sIL-10R1 re-
sults in close contacts (1 A˚) between main-chain atoms from
the IL-22 preA helix and sIL-10R1 L6 loop, which would prevent
complex formation. Likewise, when IL-10 is superimposed onto
the IL-22/sIL-22R1 complex, close contacts occur between the
AB loop of IL-10 and the L2 loop of sIL-22R1. Proper hydrogen
bonding between the IL-10 AB loop and sIL-22R1 L2 loop can
be obtained by reorienting IL-10 on the surface of IL-22R1. How-ever, this results in additional disruptions in site 1b located on the
other side of the complex. Thus, the requirement for specific
contacts in two spatially distinct regions of the interfaces, site
1a and site 1b, provides critical constraints that ensure specific-
ity between the IL-22/IL-22R1 and IL-10/IL-10R1 complexes.
Although essentially the same residues form IL-22/sIL-22R1
and IL-10/IL-10R1 site 1 interfaces, the amount of buried surface
area and the number of contacts contributed by each residue are
very different (Figure 3). For example, IL-22 AB loop residues
Thr-70IL-22 (108 A˚2), Asp-71IL-22 (74 A˚2), and Arg-73IL-22 (102
A˚2) bury the most (>70 A˚2) surface area in the IL-22/sIL-22R1
complex. Asp-44IL-10, which is structurally identical to Thr-
70IL-22, buries the most surface area (116 A˚2) of any residue in
the IL-10/sIL-10R1 complex. However, IL-10 helix A residues
bury large amounts of surface area (Pro-20IL-10, 71 A˚2;(E) Putative orientation of IL-22/IL-22R1 and IL-10/IL-10R1 cell-surface complexes. The IL-10/IL-10R1 complex is oriented so that the IL-10 dimer twofold axis is
perpendicular to the membrane. The helix A/AB loop and helix F residues of IL-10, which form the IL-10R1 binding site, are colored yellow and blue.
Structure 16, 1333–1344, September 10, 2008 ª2008 Elsevier Ltd All rights reserved 1337
Structure
Structure of IL-22/sIL-22R1 ComplexArg-24IL-10, 87 A˚2; Arg-27IL-10, 66 A˚2; Lys-34IL-10, 69 A˚2; Gln-38IL-10,
73 A˚2) into sIL-10R1, which is not observed in IL-22/sIL-22R1
(Figure 3).
Because of the extensive interactionsmade between the IL-22
AB loop and sIL-22R1, including 5 of 12 hydrogen bonds in the
interface (Table 2; Figure 3), the AB loop sequences of other
IL-10 family members were compared to determine whether
these residues were conserved in IL-20 and IL-24, which also
bind to IL-22R1. As shown in Figure 4D, IL-20 and IL-24, but
not IL-10, IL-19, or IL-26, contain two of the three IL-22 AB
loop residues (IL-20, Arg-73IL-22 and Asp-71IL-22; IL-24, Arg-
73IL-22 and Thr-70IL-22), suggesting they are important specificity
determinants that promote interactions with IL-22R1.
Promiscuous IL-10R2 Binding to IL-22/IL-22R1
and IL-10/IL-10R1 Complexes
IL-22 and IL-10 both engage the common low-affinity signal
transducing chain IL-10R2 (Kotenko et al., 1997, 2001a; Xie
et al., 2000). A previous model of the IL-10/IL-10R1/IL-10R2 ter-
nary complex, generated without any biochemical constraints,
defined the general location of the IL-10R2 binding site (Pletnev
et al., 2005). Here, our goal was to generate models of the IL-22
and IL-10 ternary signaling complexes (TC) that explain the dis-
tinct affinities of sIL-10R2 for IL-22/sIL-22R1 (Kd 14 mM) and
IL-10/sIL-10R1 (Kd 234 mM) binary complexes (Table 1). To
accomplish this, we used IL-22/sIL-22R1 and IL-10/sIL-10R1
(Josephson et al., 2001) structures and mutagenesis studies
that mapped the IL-10R2 binding sites on IL-10 (Yoon et al.,
2006) and on IL-22 (Logsdon et al., 2004) as experimental
constraints for TC model generation.
As shown in Figure 6, sIL-10R2 contacts IL-22/sIL-22R1 and
IL-10/sIL-10R1 binary complexes at three distinct surfaces
labeled sites 2a, 2b, and 2c. Sites 2a and 2b are predominantly
between sIL-10R2 and helices A and D of IL-22 and IL-10,
whereas receptor D2sIL-10R2/DsIL-22R1 or D2sIL-10R2/D2sIL-10R1 in-
teractions make up site 2c. A total of ten hydrogen bond/salt
bridge interactions was identified in the IL-22 and IL-10 site 2
interfaces (Table S2). Five of the ten interactions use the same
sIL-10R2 residue in both IL-22 and IL-10 TC complexes. The
amount of surface area buried by IL-10R2 in the IL-10 TC site
Figure 4. Comparison of IL-22/sIL-22R1 and IL-10/sIL-10R1 Interfaces
(A–C) Enlarged picture of IL-22 and IL-10 site 1 interfaces, as shown in Figure 2A, except the D1 domains of the receptors are superimposed. Important AB loop
hydrogen bonds formed in IL-22/sIL-22R1 site 1a (B) and IL-10/sIL-10R1 site 1a (C) are shown.
(D–F) Sequence alignment of IL-10 family cytokine AB loops. Interactions in IL-22/sIL-22R1 site 1b (E) and IL-10/sIL-10R1 site 1b (F) are also shown. Receptor
residue labels are distinguished from the ligand labels by underlining.
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Structure of IL-22/sIL-22R1 ComplexTable 2. Potential Hydrogen Bonds in IL-22/IL-22R1 and IL-22/IL-22BP Complexes
IL-22 IL-22R1 IL-22BPI3a IL-22BPI2a
Number Location Residue Atom Number Location Residue Atom L/R M/S Average Site Number Residue Atom Number Residue Atom Dist
44 preA Lys NZ 162 L5 Asp OD2 3.6 3.4 3.5 1b - - - 162 Glu OE1 3.0
48 preA Gln OE1 - - - - - - - 1b - - - 207 Met N 3.3
54 A Asn ND2 - - - - - - - 1b - - - 209 Asp OD1 3.4
61 A Lys NZ 111 L4 Asp OD2 2.7 3.6 3.2 1a 118 Glu OE2 118 Glu OE2 3.6
67 AB Asp OD2 112 L4 Arg NH2 3.6 3.2 3.4 1a Conserved Conserved
70 AB Thr O 61 L2 Gly N 3.1 2.9 3.0 1a Conserved Conserved
70 AB Thr OG1 58 L2 Lys NZ 2.5 3.0 2.8 1a Conserved Conserved
71 AB Asp OD1 58 L2 Lys NZ 2.8 3.0 2.9 1a Conserved Conserved
72 AB Val O 60 L2 Tyr OH 3.3 3.1 3.2 1a Conserved Conserved
73 AB Arg NH1 89 L3 Gln O 3.2 2.7 3.0 1a Conserved Conserved
73 AB Arg NH2 89 L3 Gln O 3.7 3.3 3.5 1a Conserved Conserved
162 F Lys NH1 60 L2 Tyr OH 3.1 2.9 3.0 1a Conserved Conserved
165 F Gly O 112 L4 Arg NH1 3.1 3.6 3.4 1a Conserved Conserved
166 F Glu OE2 60 L2 Tyr OH 2.4 3.0 2.7 1a Conserved Conserved
175 F Arg NH1 - - - - - - - 1b - - - 162 Glu OE1 3.0
175 F Arg NH2 - - - - - - - 1b - - - 162 Glu OE2 2.7
L/R and M/S represent distances observed between the noncrystallographic symmetry-related IL-22/IL-22R1 complexes. ‘‘Conserved’’ denotes
contacts found in the IL-22/IL-22R1 and IL-22/IL-22BP models.
a IL-22/IL-22BP contacts based on homology models.2 interface is1200 A˚2, which corresponds to an HB/100 A˚ ratio
of 0.8, which is similar to the IL-22/sIL-22R1 site 1b interface
(0.5 HB/100 A˚; Figure 4E). The IL-22 TC site 2 interface is smaller
(900 A˚2), resulting in a slightly larger HB/100 A˚ ratio of 1.1.
In addition to characterizing the low-affinity binding properties
of site 2, the TCmodels suggest that structural differences in the
ligands determine IL-10R2 affinity for IL-22 and IL-10 binary
complexes. In the IL-22 TC, the N-terminal end of helix A pres-
ents a knob-like surface for interactions with the binding loops
of sIL-10R2 (Figure 2E). In contrast, the surface presented by he-
lix A in IL-10 is essentially flat, which is consistent with its lower
affinity for IL-10R2. Arg-55IL-22 and Arg-32IL-10 both form con-
served salt-bridge interactions with Asp-84sIL-10R2, but structural
differences that could alter sIL-10R2 affinity are present. Specif-
ically, the side-chain conformation of Arg-55IL-22 is fixed by ad-
ditional contacts with Tyr-51IL-22, whereas there are no such
constraints on Arg-32IL-10. These findings are consistent with
the 120 mM affinity of the IL-22/IL-10R2 interaction compared
to the mM affinity of the IL-10/IL-10R2 interaction (Table 1).
The most extensive contacts in the IL-10 TC are observed in
site 2b, which consists of the tripartite interaction between
Arg-24IL-10, the L6 loop of sIL-10R1, and Asn-147sIL-10R2. In
a manner similar to the presentation of Arg-55IL-22 on the knob
of IL-22, sIL-10R1 interactions with Arg-24IL-10 orient the side
chain for interactions with Asn-147sIL-10R2. The most diverse
contacts in the IL-22 and IL-10 TCs occur in site 2c. In particular,
Glu-121sIL-10R2 forms a hydrogen bond with Ser-174sIL-10R1 in
the IL-10 TC. However, in the IL-22 TC, Glu-121sIL-10R2 interacts
with the N-acetylglucosamine attached to Asn-174sIL-22R1 (Fig-
ures 2D, 2E, and 6). This is especially interesting because previ-
ous characterization of IL-22/sIL-10R2 interactions found carbo-
hydrate attached to Asn-54IL-22 to be important for sIL-10R2
binding (Logsdon et al., 2004).Structure 16, 1333–13DISCUSSION
IL-22 folds into a compactmonomeric structure, in contrast to IL-
10,whichassembles intodomain-swappeddimers (Nagemet al.,
2002; Walter and Nagabhushan, 1995; Xu et al., 2005; Zdanov
et al., 1995). Interestingly, recent X-ray scattering data revealed
that IL-22 forms noncovalent dimers, and tetramers, in solution
that adopt V-shaped structures similar to the IL-10 dimer (de Oli-
veira Neto et al., 2008). Although we do not observe an IL-10-like
dimer complex in the crystal lattice, it is clear that IL-22 and IL-10
form receptor complexes with very similar architectures. This
suggests that the overall receptor complex structure, with the
exception of oligomerization (e.g., monomer/dimer transition), is
not responsible for differences in IL-22 and IL-10 signaling.
FRET data have revealed that IL-10R1 and IL-10R2 associate
with one another on the cell surface in the absence of IL-10
(Krause et al., 2006). Because IL-22R1 pairs with IL-10R2 to in-
duce IL-22 signaling, IL-22R1 and IL-10R2 are also predicted
to form cell-surface heterodimers (Krause et al., 2006). Based
on mechanistic studies of growth hormone and erythropoietin
signaling, binding of IL-22 and IL-10 to their respective R1/R2
heterodimers is expected to induce rotational and/or conforma-
tional changes in the receptors leading to cell signaling (Brown
et al., 2005; Remy et al., 1999). Althoughmany of the general fea-
tures of the IL-22 and IL-10 signaling complexes are conserved,
IL-22 and IL-10 exhibit unique specificities and receptor binding
kinetics, which are dependent on the structural details of the site
1 and site 2 interfaces. IL-22/IL-22R1 and IL-10/IL-10R1 site 1
contacts exhibit Kd values (nM) that are at least four orders of
magnitude higher than site 2 contacts made by the common
IL-10R2 chain (mM).
Because of the large differences in the site 1 and site 2 binding
affinity/kinetics, IL-22 and IL-10 TC activation are R1 dominant.44, September 10, 2008 ª2008 Elsevier Ltd All rights reserved 1339
Structure
Structure of IL-22/sIL-22R1 ComplexFigure 5. Binding and Structure of IL-22BP Isoforms
(A) Short (7 min) and long (22 hr, inset) period sensorgrams used to derive the affinity of the IL-22/IL-22BPI2 interaction (see Table 1).
(B) Sensorgram performed using IL-22BPI3-His6 captured to anti-His Ab surfaces, followed by the injection of IL-22. Larger versions of the sensorgram are shown
in Figure S1.
(C) Homologymodel of IL-22BPI2 colored to show the location of residue differences and similarities with sIL-22R1. Residues conserved between IL-22BPI2 and
sIL-22R1 are colored cyan, and differences are colored magenta. The orange residue, Pro-111IL-22BP, highlights the one amino change in D1 that alters contacts
with IL-22.
(D) Site 1b interface observed in the IL-22/IL-22BPI2 homology model.
(E) Model of the IL-22BPI3 colored as described in (C). Unique C-terminal residues of IL-22BPI3 are shown in yellow.
(F) Sequence alignment of sIL-22R1 and IL-22BP isoforms. sIL-22R1 residues that bind IL-22 are labeled with red dots.
1340 Structure 16, 1333–1344, September 10, 2008 ª2008 Elsevier Ltd All rights reserved
Structure
Structure of IL-22/sIL-22R1 ComplexThis suggests that despite the preassociation of R1 and R2
chains on the cell surface, cell specificity/targeting and receptor
occupancy time are controlled by the binding kinetics of the R1
chains, which are selectively expressed on different cell types
(Nagalakshmi et al., 2004). In contrast to IL-22R1 and IL-10R1,
IL-10R2 is ubiquitously expressed on all cell types (Nagalakshmi
et al., 2004). The weak binding of IL-10R2, via site 2, suggests
that it functions as a sensor chain which activates signaling
based on the kinetics of the R1 chain, via site 1.Weak site 2 bind-
ing also promotes promiscuous IL-10R2 interactions with IL-22,
Figure 6. Models of the IL-22/IL-22R1/
IL-10R2 and IL-10/IL-10R1/IL-10R2 Ternary
Complexes
Overall IL-22 (A) and IL-10 (B) ternary complex
structures. Enlarged pictures of the IL-22 (C) and
IL-10 (D) site 2a/2b and IL-22 (E) and IL-10 (F)
site 2c are also shown.
IL-10, and other cytokines (IL-26, IL-28,
and IL-29), and reduces the number of
unique chains required for IL-10 family
cytokine signaling. Our conclusions,
based on SPR data, agree with IL-10
cell-surface binding studies that reveal
that IL-10 binds to cells expressing only
the IL-10R1 chain with an identical affinity
as cells expressing both IL-10R1 and IL-
10R2 (Ding et al., 2001).
Additional regulationof IL-22cell target-
ing/signaling is suggestedby the structure
and binding properties of IL-22BP iso-
forms. Our analysis suggests that IL-22/
IL-22BPI2 forms an extremely tight (Kd
1 pM) interaction with IL-22, which dif-
fers considerably from the 1 nM Kd ob-
tained by another recent SPR analysis of
the IL-22/IL-22BPI2 complex (Wolk et al.,
2007). Possible reasons for these discrep-
ancies are the use of amine-coupled IL-22
by Wolk et al., which can lead to reduced
on-rates, and the use of short dissociation
times, which can underestimate slow
off-rates. Also in contrast to Wolk et al.,
our capture experiments suggest that
sIL-22R1 and IL-22BPI2 exhibit essen-
tially identical on-rates. However, the off-
rates differ dramatically, resulting in T1/2
values of7 min for IL-22/sIL-22R1 com-
pared to4.7 days for IL-22/IL-22BP. The
impact of these findings on IL-22 biology
depends on IL-22, IL-22R1, and IL-22BP
levels in various tissues, which are now
being explored in more detail.
SPR analysis of IL-22BPI3 reveals that
it displays binding kinetics similar to the
IL-22/sIL-22R1 complex. Analysis of IL-
22BPI3 confirms the importance of site
1a for IL-22 binding and the small role of site 1b in IL-22/
sIL-22R1 interactions. The functional role of the IL-22BPI3
isoforms remains unclear. Relative to IL-22BPI2, IL-22BPI3 is
essentially inactive due to an2800-fold reduction in IL-22 affin-
ity, which suggests splicing may be a mechanism to inactivate
IL-22BPI2. However, because IL-22BPI3 does retain sIL-22R1-
like affinity for IL-22, it is formally possible that IL-22/IL-22BPI3
complexes have a yet unknown role in IL-22 biology.
In addition to providing a structural model that explains ob-
served IL-10R2 affinities and promiscuity, the IL-22 TC model
Structure 16, 1333–1344, September 10, 2008 ª2008 Elsevier Ltd All rights reserved 1341
Structure
Structure of IL-22/sIL-22R1 Complexhas also revealed a possible role for N-linked glycosylation in
IL-22R1/IL-10R2 site 2c interactions. This is interesting because
carbohydrate attached to IL-22 (Asn-54IL-22) was previous
shown to be important for IL-10R2 binding (Logsdon et al.,
2004). Docking studies were performed in the presence of
Asn-54IL-22-linked carbohydrate obtained from the crystal struc-
ture of glycosylated IL-22 (Xu et al., 2005). Thus, the IL-22 TC
contains sufficient space to accommodate N-linked carbohy-
drate between sIL-22R1 and sIL-10R2, but an explanation for
how mutation of Asn-54IL-22 to glutamine disrupts sIL-10R2
binding and cell signaling could not be identified (Logsdon
et al., 2004). This may be due to errors in the modeled sIL-
10R2 loops, or Asn-54IL-22 may play an indirect role (e.g., medi-
ate conformational changes) in activating the IL-22 TC.
In addition to IL-22 signaling complexes, IL-22R1 alongwith IL-
20R2 also form promiscuous IL-20 and IL-24 TCs. However, IL-
20/sIL-22R1 interactionsareweak,basedonour inability to isolate
a stable IL-20/sIL-22R1 complex by size-exclusion chromatogra-
phy (N.J.L. and M.R.W., unpublished results). Thus, in contrast to
the R1-dominant IL-22 and IL-10 signaling complexes, sIL-22R1
appears to play a different role in IL-20 and IL-24 complexes.
We have identified two critical recognition elements that facilitate
promiscuous binding by IL-22R1. First, IL-20 and IL-24 conserve
two of three IL-22 AB loop residues (Thr-70IL-22, Asp-71IL-22, and
Arg-73IL-22) that form extensive contacts with sIL-22R1. Second,
the low affinity of IL-20/sIL-22R1 is consistent with the small site
1b interface observed in IL-22/sIL-22R1, which in our specificity
model is critical for promiscuous contacts. The necessity of these
affinity and specificity differences may allow fine-tuning of IL-19,
IL-20, and IL-24 signaling via IL-22R1/IL-20R1 versus IL-20R1/
IL-20R2 complexes in the skin compared to other tissues. The
detailed structural basis that regulates these distinct signaling
mechanisms will be the focus of future investigations.
EXPERIMENTAL PROCEDURES
Crystallization, Data Collection, and Structure Determination
Crystals of the IL-22/sIL-22R1 complex were obtained as described by Jones
et al. (2008). X-ray diffraction data were collected at the Southeast Regional
Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced
Photon Source, Argonne National Laboratory, Argonne, Illinois. The structure
of the IL-22/sIL-22R1 complex was solved by molecular replacement, using
MOLREP (CCP4, 1994) and SAD phasing methods implemented in CNS ver-
sion 1.1 (Brunger et al., 1998). The sIL-22R1 model was built using O (Jones
et al., 1991). Buried surface area was calculated using NACCESS (Hubbard
and Thorton, 1993). Structural alignments were performed using STAMP (Rus-
sell and Barton, 1992) implemented in VMD (Humphrey et al., 1996). Figures
were made using Ribbons and PyMOL (Carson, 1997; DeLano, 2002).
Modeling
IL-22BP and IL-10R2 models were made using MODELER version 8.1 (Eswar
et al., 2003). sIL-22R1 and IL-10R1 were used as the structural templates for
IL-22BP and IL-10R2 model generation, respectively, using the sequence
alignments shown in Figure 5 and Figure S2. sIL-10R2 docking was performed
manually using PyMOL (DeLano, 2002) such that IL-10R2 exhibited essentially
identical positions in the IL-22 and IL-10 TC complexes and was consistent
with major findings of the mutagenesis data (Logsdon et al., 2004; Yoon
et al., 2006).
SPR Analysis
SPR experiments were performed on a Biacore 2000 system at 20C using an
HBS running buffer containing 10 mM HEPES (pH 7.4), 0.15 M NaCl, and1342 Structure 16, 1333–1344, September 10, 2008 ª2008 Elsevier0.005% P20 (Biacore). SPR capture experiments were performed by amine
coupling 4000 RU of anti-His monoclonal antibody (PHAb; 150 mM NaCl,
20 mM Tris [pH 8]; PentaHis, QIAGEN) on CM-5 research-grade surfaces. C-
terminal His6 constructs sIL-22R1, sIL-22R1DDQ, IL-22BPI2, or IL-22BPI3, ex-
pressed as described by Logsdon et al. (2004), were injected over the PHAb
surface until a total of 120 RU had been captured. Ten different concentrations
of IL-22, including a buffer control, were injected over the sIL-22R1, IL-22BPI2,
or IL-22BPI3 surfaces in random order at 50 ml/min for 2 min and the dissoci-
ation phase was monitored for 7.5 min. Following each IL-22 injection, the
PHab surface was cleaned with 0.1 M glycine, 0.5 M NaCl (pH 4.0) followed
by fresh receptor and/or binding protein. Reproducible capture wasmonitored
by pre- and postcapture report points, which varied by less than 5 RU. The re-
sponse curves were globally fit using BIAevaluation version 3.2, which gave
equivalent parameters to data analysis using CLAMP version 3.1 (Myszka
and Morton, 1998). IL-22BPI2 off-rates were measured as previously de-
scribed by Logsdon et al. (2004) except the chip surfaces were saturated by
injecting 1 mM IL-22BPI2 (2 min contact time) at 50 ml/min and dissociation
was followed using a data collection rate of 1 point per 10 s for 22 hr.
ACCESSION NUMBERS
Coordinates and structure factors of the IL-22/sIL-22R1 complex have been
deposited in the Protein Data Bank under ID code 3DGC.
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with this article online at http://www.structure.org/cgi/content/full/16/9/
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